109
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Lipid Profile and Risk of Incident Systemic Sclerosis: A Nationwide Population-Based Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1095-1107 | Received 19 Jul 2023, Accepted 04 Nov 2023, Published online: 28 Nov 2023

References

  • Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–1699. doi:10.1016/s0140-6736(17)30933-9
  • Ruaro B, Smith V, Sulli A, et al. Innovations in the assessment of primary and secondary raynaud’s phenomenon. Front Pharmacol. 2019;10:360. doi:10.3389/fphar.2019.00360
  • Bergamasco A, Hartmann N, Wallace L, Verpillat P. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol. 2019;11:257–273. doi:10.2147/clep.S191418
  • Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809–1815. doi:10.1136/ard.2009.114264
  • Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. Qjm. 2010;103(2):109–115. doi:10.1093/qjmed/hcp174
  • Murdaca G, Contatore M, Gulli R, Mandich P, Puppo F. Genetic factors and systemic sclerosis. Autoimmun Rev. 2016;15(5):427–432. doi:10.1016/j.autrev.2016.01.016
  • Makino T, Jinnin M. Genetic and epigenetic abnormalities in systemic sclerosis. J Dermatol. 2016;43(1):10–18. doi:10.1111/1346-8138.13221
  • Silman AJ, Newman J. Genetic and environmental factors in scleroderma. Curr Opin Rheumatol. 1994;6(6):607–611. doi:10.1097/00002281-199411000-00010
  • Abbot S, Bossingham D, Proudman S, de Costa C, Ho-Huynh A. Risk factors for the development of systemic sclerosis: a systematic review of the literature. Rheumatol Adv Pract. 2018;2(2):rky041. doi:10.1093/rap/rky041
  • Pauling JD, McGrogan A, Snowball J, McHugh NJ. Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink. Rheumatology. 2021;60(6):2688–2696. doi:10.1093/rheumatology/keaa680
  • Delisle VC, Hudson M, Baron M, Thombs BD; And The Canadian Scleroderma Research Group A. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1129 patients from the Canadian scleroderma research group registry. Clin Exp Rheumatol. 2014;32(6 Suppl 86):10–14.
  • Sakkas LI, Simopoulou T, Katsiari C, Bogdanos D, Chikanza IC. Early systemic sclerosis-opportunities for treatment. Clin Rheumatol. 2015;34(8):1327–1331. doi:10.1007/s10067-015-2902-5
  • Melissaropoulos K, Kraniotis P, Bogdanos D, Dimitroulas T, Sakkas L, Daoussis D. Targeting very early systemic sclerosis: a case-based review. Rheumatol Int. 2019;39(11):1961–1970. doi:10.1007/s00296-019-04357-x
  • Gogulska Z, Smolenska Z, Turyn J, Mika A, Zdrojewski Z. Lipid Alterations in Systemic Sclerosis. Front Mol Biosci. 2021;8:761721. doi:10.3389/fmolb.2021.761721
  • Chen W, Wang Q, Zhou B, Zhang L, Zhu H. Lipid Metabolism Profiles in Rheumatic Diseases. Front Pharmacol. 2021;12:643520. doi:10.3389/fphar.2021.643520
  • Han X. Lipidomics for studying metabolism. Nat Rev Endocrinol. 2016;12(11):668–679. doi:10.1038/nrendo.2016.98
  • Robinson G, Pineda-Torra I, Ciurtin C, Jury EC. Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J Clin Invest. 2022;132(2). doi:10.1172/jci148552
  • Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 1995;38(8):1060–1067. doi:10.1002/art.1780380807
  • Borba EF, Borges CT, Bonfá E. Lipoprotein profile in limited systemic sclerosis. Rheumatol Int. 2005;25(5):379–383. doi:10.1007/s00296-004-0580-8
  • Kotyla PJ, Gozdzik J, Lewicki M, Kotulska AT, Kucharz EJ. Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state. Rheumatol Int. 2006;26(6):583–584. doi:10.1007/s00296-005-0075-2
  • Kim HB, Kim A, Kim Y, et al. Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis. Scand J Rheumatol. 2021;50(3):231–238. doi:10.1080/03009742.2020.1837237
  • Ferraz-Amaro I, Delgado-Frías E, Hernández-Hernández V, et al. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis. Arthritis Res Ther. 2021;23(1):62. doi:10.1186/s13075-021-02443-9
  • Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–728. doi:10.3346/jkms.2017.32.5.718
  • Kwon OC, Han K, Chun J, et al. Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study. Sci Rep. 2022;12(1):11548. doi:10.1038/s41598-022-15436-8
  • Kang GW, Jung KH, Lee YS, et al. Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study. Br J Dermatol. 2018;178(1):e37–e39. doi:10.1111/bjd.15838
  • Hong S, Park JH, Han K, Lee CB, Kim DS, Yu SH. Association between obesity and cardiovascular disease in elderly patients with diabetes: a retrospective cohort study. J Clin Endocrinol Metab. 2022;107(2):e515–e527. doi:10.1210/clinem/dgab714
  • Kwak SK, Kim JH. Statistical data preparation: management of missing values and outliers. Korean J Anesthesiol. 2017;70(4):407–411. doi:10.4097/kjae.2017.70.4.407
  • Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010;69(7):1310–1314. doi:10.1136/ard.2009.122374
  • van Halm VP, Nielen MM, Nurmohamed MT, et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis. 2007;66(2):184–188. doi:10.1136/ard.2006.051672
  • Soh H, Im JP, Han K, et al. Crohn’s disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study. Aliment Pharmacol Ther. 2020;51(4):446–456. doi:10.1111/apt.15562
  • Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol. 1993;22(3):933–940. doi:10.1016/0735-1097(93)90213-k
  • Vermont CL, den Brinker M, Kâkeci N, et al. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med. 2005;33(7):1610–1615. doi:10.1097/01.ccm.0000171272.50888.ad
  • Akgün S, Ertel NH, Mosenthal A, Oser W. Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J Lab Clin Med. 1998;131(1):103–108. doi:10.1016/s0022-2143(98)90083-x
  • Negre-Salvayre A, Dousset N, Ferretti G, Bacchetti T, Curatola G, Salvayre R. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med. 2006;41(7):1031–1040. doi:10.1016/j.freeradbiomed.2006.07.006
  • Norata GD, Pirillo A, Ammirati E, Catapano AL. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis. 2012;220(1):11–21. doi:10.1016/j.atherosclerosis.2011.06.045
  • Davis CE, Williams DH, Oganov RG, et al. Sex difference in high density lipoprotein cholesterol in six countries. Am J Epidemiol. 1996;143(11):1100–1106. doi:10.1093/oxfordjournals.aje.a008686
  • Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772–783. doi:10.1038/nri1937
  • Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. doi:10.1038/nri2925
  • Pirro M, Simental-Mendía LE, Bianconi V, Watts GF, Banach M, Sahebkar A. Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET/CT: a systematic review and meta-analysis of interventional studies. J Clin Med. 2019;8(1):118. doi:10.3390/jcm8010118
  • Ju HB, Zhang FX, Wang S, et al. Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients. Medicine. 2017;96(31):e7671. doi:10.1097/md.0000000000007671
  • Ghanim H, Green K, Abuaysheh S, et al. Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients. Atherosclerosis. 2017;263:278–286. doi:10.1016/j.atherosclerosis.2017.06.010
  • Min YS, Kim MG, Ahn YS. Rheumatoid arthritis in silica-exposed workers. Int J Environ Res Public Health. 2021;18(23). doi:10.3390/ijerph182312776